Intravacc is a leading organisation in the field of biopharmaceuticals, specialising in contract development and manufacturing (CDMO) services for the vaccine industry. With many years of experience in translational vaccinology, Intravacc effectively reduces the risks and costs associated with vaccine development by bridging the gap between client concepts and late-stage clinical studies. Based in the Netherlands at the Utrecht Science Park in Bilthoven, Intravacc supports clients in advancing their vaccine candidates from initial discovery through to the start of human phase I/II clinical trials.

Services include:
– Clinical trial material manufacturing
– Process development and optimisation
– Quality assurance and regulatory support
– Vaccine formulation and characterisation
– Analytical development and testing
– Preclinical and clinical trial support
– Pilot production and scale-up

Intravacc is dedicated to enhancing the vaccine development process, providing comprehensive support to its clients at every stage. For more information, visit intravacc.nl.